AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity

Journal of Lipid Research

Volumn 53, Issue 7, 2012, Pages 1277-1286

  Lee, Joo Won ^a   Choe, Sung Sik ^a   Jang, Hagoon ^a   Kim, Jiyeong ^b   Jeong, Hyun Woo ^a   Jo, Hyunsun ^a   Jeong, Kyeong Hoon ^c   Tadi, Surendar ^d,e   Park, Myoung Gyu ^f   Kwak, Tae Hwan ^f   Kim, Jin Man ^d   Hyun, Dong Hoon ^b   Kim, Jae Bum ^a,b  

^a Seoul National University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

^e Korea Research Institute of Standards and Science   (South Korea)

^f Mazence Co Ltd   (South Korea)

Author keywords

AMP activated protein kinase; Fatty acid oxidation; Fatty liver

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ACYL COENZYME A OXIDASE; ANTIDIABETIC AGENT; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; FATTY ACID SYNTHASE; GLABRIDIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERINSULINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MITOCHONDRION; MOUSE; MUSCLE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE;

ADIPOSITY; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BODY WEIGHT; FATTY ACIDS; ISOFLAVONES; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MITOCHONDRIA; OBESITY; PHENOLS; PHOSPHORYLATION;

EID: 84862314784     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M022897     Document Type: Article

References (60)

1. Kopelman, P. G. 2000. Obesity as a medical problem. Nature. 404: 635-643. (Pubitemid 30205068)
2. Borkman, M., L. H. Storlien, D. A. Pan, A. B. Jenkins, D. J. Chisholm, and L. V. Campbell. 1993. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328: 238-244. (Pubitemid 23035309)
3. Goodpaster, B. H., F. L. Thaete, J. A. Simoneau, and D. E. Kelley. 1997. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 46: 1579-1585. (Pubitemid 27411233)
4. Kahn, B. B., and J. S. Flier. 2000. Obesity and insulin resistance. J. Clin. Invest. 106: 473-481. (Pubitemid 30666380)
5. Hardie, D. G. 2008. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.) 32(Suppl. 4): S7-S12.
6. Zhang, B. B., G. Zhou, and C. Li. 2009. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9: 407-416.
7. Hardie, D. G., I. P. Salt, S. A. Hawley, and S. P. Davies. 1999. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338: 717-722. (Pubitemid 29140078)
8. Hawley, S. A., D. A. Pan, K. J. Mustard, L. Ross, J. Bain, A. M. Edelman, B. G. Frenguelli, and D. G. Hardie. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2: 9-19. (Pubitemid 43239821)
9. Sanders, M. J., P. O. Grondin, B. D. Hegarty, M. A. Snowden, and D. Carling. 2007. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403: 139-148. (Pubitemid 46569875)
10. Woods, A., K. Dickerson, R. Heath, S. P. Hong, M. Momcilovic, S. R. Johnstone, M. Carlson, and D. Carling. 2005. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2: 21-33. (Pubitemid 43239822)
11. Atkinson, L. L., M. A. Fischer, and G. D. Lopaschuk. 2002. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J. Biol. Chem. 277: 29424-29430. (Pubitemid 41079226)
12. Kudo, N., A. J. Barr, R. L. Barr, S. Desai, and G. D. Lopaschuk. 1995. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270: 17513-17520.
13. Merrill, G. F., E. J. Kurth, D. G. Hardie, and W. W. Winder. 1997. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273: E1107-E1112.
14. Reznick, R. M., and G. I. Shulman. 2006. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 574: 33-39. (Pubitemid 43905794)
15. Suwa, M., T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai. 2006. Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J. Appl. Physiol. 101: 1685-1692. (Pubitemid 44904490)
16. Suwa, M., H. Nakano, and S. Kumagai. 2003. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. 95: 960-968. (Pubitemid 37033988)
17. Zong, H., J. M. Ren, L. H. Young, M. Pypaert, J. Mu, M. J. Birnbaum, and G. I. Shulman. 2002. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA. 99: 15983-15987. (Pubitemid 35462735)
18. Andreelli, F., M. Foretz, C. Knauf, P. D. Cani, C. Perrin, M. A. Iglesias, B. Pillot, A. Bado, F. Tronche, G. Mithieux, et al. 2006. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology. 147: 2432-2441.
19. Viollet, B., M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue, and F. Andreelli. 2006. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol. 574: 41-53. (Pubitemid 43905795)
20. Cantó, C., Z. Gerhart-Hines, J. N. Feige, M. Lagouge, L. Noriega, J. C. Milne, P. J. Elliott, P. Puigserver, and J. Auwerx. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 458: 1056-1060.
21. Cantó, C., L. Q. Jiang, A. S. Deshmukh, C. Mataki, A. Coste, M. Lagouge, J. R. Zierath, and J. Auwerx. 2010. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11: 213-219.
22. Chau, M. D., J. Gao, Q. Yang, Z. Wu, and J. Gromada. 2010. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc. Natl. Acad. Sci. USA. 107: 12553-12558.
23. Fulco, M., Y. Cen, P. Zhao, E. P. Hoffman, M. W. McBurney, A. A. Sauve, and V. Sartorelli. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell. 14: 661-673. (Pubitemid 351622608)
24. Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, et al. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108: 1167-1174. (Pubitemid 32995375)
25. Hawley, S. A., J. Boudeau, J. L. Reid, K. J. Mustard, L. Udd, T. P. Makela, D. R. Alessi, and D. G. Hardie. 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2: 28.
26. Fryer, L. G., A. Parbu-Patel, and D. Carling. 2002. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277: 25226-25232. (Pubitemid 34951829)
27. Ahn, J., H. Lee, S. Kim, J. Park, and T. Ha. 2008. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 373: 545-549.
28. Baur, J. A., K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin, A. Kalra, V. V. Prabhu, J. S. Allard, G. Lopez-Lluch, K. Lewis, et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444: 337-342. (Pubitemid 44764104)
29. Lee, Y. S., W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J. M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, et al. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 55: 2256-2264. (Pubitemid 44743622)
30. Kim, W. S., Y. S. Lee, S. H. Cha, H. W. Jeong, S. S. Choe, M. R. Lee, G. T. Oh, H. S. Park, K. U. Lee, M. D. Lane, et al. 2009. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am. J. Physiol. Endocrinol. Metab. 296: E812-E819.
31. Rosenblat, M., P. Belinky, J. Vaya, R. Levy, T. Hayek, R. Coleman, S. Merchav, and M. Aviram. 1999. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J. Biol. Chem. 274: 13790-13799.
32. Carmeli, E., and Y. Fogelman. 2009. Antioxidant effect of polyphenolic glabridin on LDL oxidation. Toxicol. Ind. Health. 25: 321-324.
33. Mae, T., H. Kishida, T. Nishiyama, M. Tsukagawa, E. Konishi, M. Kuroda, Y. Mimaki, Y. Sashida, K. Takahashi, T. Kawada, et al. 2003. A licorice ethanolic extract with peroxisome proliferator-activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J. Nutr. 133: 3369-3377. (Pubitemid 37409461)
34. Nakagawa, K., H. Kishida, N. Arai, T. Nishiyama, and T. Mae. 2004. Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice. Biol. Pharm. Bull. 27: 1775-1778. (Pubitemid 41701602)
35. Aoki, F., S. Honda, H. Kishida, M. Kitano, N. Arai, H. Tanaka, S. Yokota, K. Nakagawa, T. Asakura, Y. Nakai, et al. 2007. Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci. Biotechnol. Biochem. 71: 206-214. (Pubitemid 46155164)
36. Kamisoyama, H., K. Honda, Y. Tominaga, S. Yokota, and S. Hasegawa. 2008. Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats. Biosci. Biotechnol. Biochem. 72: 3225-3231.
37. Honda, K., H. Kamisoyama, Y. Tominaga, S. Yokota, and S. Hasegawa. 2009. The molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high fat diet-induced obese rats. Anim. Sci. J. 80: 562-569.
38. Yoon, M. J., G. Y. Lee, J. J. Chung, Y. H. Ahn, S. H. Hong, and J. B. Kim. 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes. 55: 2562-2570.
39. Choe, S. S., A. H. Choi, J. W. Lee, K. H. Kim, J. J. Chung, J. Park, K. M. Lee, K. G. Park, I. K. Lee, and J. B. Kim. 2007. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes. 56: 1534-1543. (Pubitemid 46842606)
40. Kim, K. H., G. Y. Lee, J. I. Kim, M. Ham, J. Won Lee, and J. B. Kim. 2010. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J. Lipid Res. 51: 3425-3433.
41. Vives-Bauza, C., L. Yang, and G. Manfredi. 2007. Assay of mitochondrial ATP synthesis in animal cells and tissues. Methods Cell Biol. 80: 155-171.
42. Janssen, A. J., F. J. Trijbels, R. C. Sengers, J. A. Smeitink, L. P. van den Heuvel, L. T. Wintjes, B. J. Stoltenborg-Hogenkamp, and R. J. Rodenburg. 2007. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin. Chem. 53: 729-734. (Pubitemid 46580245)
43. Stocchi, V., L. Cucchiarini, M. Magnani, L. Chiarantini, P. Palma, and G. Crescentini. 1985. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146: 118-124. (Pubitemid 15093059)
44. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259: 87-91. (Pubitemid 23036092)
45. Hawley, S. A., F. A. Ross, C. Chevtzoff, K. A. Green, A. Evans, S. Fogarty, M. C. Towler, L. J. Brown, O. A. Ogunbayo, A. M. Evans, et al. 2010. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11: 554-565.
46. Hou, X., S. Xu, K. A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T. J. Verbeuren, et al. 2008. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283: 20015-20026.
47. Shen, Z., X. Liang, C. Q. Rogers, D. Rideout, and M. You. 2010. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G364-G374.
48. Gerhart-Hines, Z., J. T. Rodgers, O. Bare, C. Lerin, S. H. Kim, R. Mostoslavsky, F. W. Alt, Z. Wu, and P. Puigserver. 2007. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 26: 1913-1923. (Pubitemid 46624046)
49. Rodgers, J. T., and P. Puigserver. 2007. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc. Natl. Acad. Sci. USA. 104: 12861-12866. (Pubitemid 47255245)
50. Hu, Z., S. H. Cha, S. Chohnan, and M. D. Lane. 2003. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc. Natl. Acad. Sci. USA. 100: 12624-12629. (Pubitemid 37339949)
51. Minokoshi, Y., T. Alquier, N. Furukawa, Y. B. Kim, A. Lee, B. Xue, J. Mu, F. Foufelle, P. Ferre, M. J. Birnbaum, et al. 2004. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 428: 569-574. (Pubitemid 38480541)
52. Andersson, U., K. Filipsson, C. R. Abbott, A. Woods, K. Smith, S. R. Bloom, D. Carling, and C. J. Small. 2004. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279: 12005-12008. (Pubitemid 38445761)
53. Cha, S. H., Z. Hu, S. Chohnan, and M. D. Lane. 2005. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc. Natl. Acad. Sci. USA. 102: 14557-14562. (Pubitemid 41457096)
54. Cha, S. H., J. T. Rodgers, P. Puigserver, S. Chohnan, and M. D. Lane. 2006. Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: role of PGC-1alpha. Proc. Natl. Acad. Sci. USA. 103: 15410-15415. (Pubitemid 44625605)
55. Day, P., A. Sharff, L. Parra, A. Cleasby, M. Williams, S. Horer, H. Nar, N. Redemann, I. Tickle, and J. Yon. 2007. Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP. Acta Crystallogr. D Biol. Crystallogr. 63: 587-596. (Pubitemid 46661530)
56. Brunmair, B., K. Staniek, F. Gras, N. Scharf, A. Althaym, R. Clara, M. Roden, E. Gnaiger, H. Nohl, W. Waldhausl, et al. 2004. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes. 53: 1052-1059. (Pubitemid 38436618)
57. El-Mir, M. Y., V. Nogueira, E. Fontaine, N. Averet, M. Rigoulet, and X. Leverve. 2000. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275: 223-228. (Pubitemid 30038975)
58. Turner, N., J. Y. Li, A. Gosby, S. W. To, Z. Cheng, H. Miyoshi, M. M. Taketo, G. J. Cooney, E. W. Kraegen, D. E. James, et al. 2008. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 57: 1414-1418.
59. Jeong, H. W., K. C. Hsu, J. W. Lee, M. Ham, J. Y. Huh, H. J. Shin, W. S. Kim, and J. B. Kim. 2009. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 296: E955-E964.
60. Kwon, H. S., S. M. Oh, and J. K. Kim. 2008. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin. Exp. Immunol. 151: 165-173.